Personalized cardiac models
Our tissues can assess which populations may benefit most from a given treatment.
Clinical trials in-a-dish
TARA’s Cardiotype tissues can be generated from patient-specific iPSC-derived cardiomyocytes. This enables segmentation of patient subgroups for evaluation in advance of expensive clinical trials.
Genotype to phenotype to human
Our phenotypic data bridges the continuum of the genotypic data to human physiology. TARA allows for integrated phenotyping before, during, and after drug treatment.
Cardiotype is TARA’s mature cardiac tissue engineered from induced-pluripotent stem cells (iPSCs). It reproduces the physiological hallmarks of the human heart and provides an integrated analysis of cardiac function, with both healthy and diseased models. Learn who will benefit the most from your treatment.